✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals
Market Cap
₹78 Cr.
P/E
15.74
  • Onyx Biotec
  • Cohance Lifesciences
  • JB Chem & Pharma

FAQs on Onyx Biotec Ltd. Shareprice

There is not enough historical data for the companies share price.

Onyx Biotec is not expensive.
Latest PE of Onyx Biotec is 15.74, while 3 year average PE is 29.77.
Also latest EV/EBITDA of Onyx Biotec is 0 while 3yr average is 16.35.

Growth Table

  • Onyx Biotec Ltd.
  • Cohance Lifesciences
  • JB Chem & Pharma

Balance Sheet

  • Onyx Biotec Ltd.
  • Cohance Lifesciences
  • JB Chem & Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Onyx Biotec Ltd.
  • Cohance Lifesciences
  • JB Chem & Pharma

Cash Flow

  • Onyx Biotec Ltd.
  • Cohance Lifesciences
  • JB Chem & Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Onyx Biotec Ltd.
  • Cohance Lifesciences
  • JB Chem & Pharma

Quarterly Results

  • Onyx Biotec Ltd.
  • Cohance Lifesciences
  • JB Chem & Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Onyx Biotec Ltd. Financials

Balance sheet of Onyx Biotec is moderately strong, But short term working capital might become an issue for this company.

The net debt of Onyx Biotec is decreasing.
Latest net debt of Onyx Biotec is ₹3.85 Crs as of Mar-25.
This is less than Mar-24 when it was ₹27.86 Crs.

Yes, profit is increasing.
The profit of Onyx Biotec is ₹4.95 Crs for TTM, ₹3.03 Crs for Mar 2024 and ₹1.84 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Onyx Biotec latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech